BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7025159)

  • 1. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.
    Hilleman MR; Carlson AJ; McLean AA; Vella PP; Weibel RE; Woodhour AF
    Rev Infect Dis; 1981; 3 Suppl():S31-42. PubMed ID: 7025159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older.
    Frenck RW; Fiquet A; Gurtman A; van Cleeff M; Davis M; Rubino J; Smith W; Sundaraiyer V; Sidhu M; Emini EA; Gruber WC; Scott DA; Schmoele-Thoma B;
    Vaccine; 2016 Jun; 34(30):3454-62. PubMed ID: 27155493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines.
    Sell SH; Wright PF; Vaughn WK; Thompson J; Schiffman G
    Rev Infect Dis; 1981; 3 Suppl():S97-107. PubMed ID: 7280450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination.
    Mufson MA; Hughey DF; Turner CE; Schiffman G
    Vaccine; 1991 Jun; 9(6):403-7. PubMed ID: 1887670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens.
    Siber GR; Weitzman SA; Aisenberg AC
    Rev Infect Dis; 1981; 3 Suppl():S144-59. PubMed ID: 7280445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage.
    Wright PF; Sell SH; Vaughn WK; Andrews C; McConnell KB; Schiffman G
    Rev Infect Dis; 1981; 3 Suppl():S108-12. PubMed ID: 7280442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly.
    Honkanen PO; Keistinen T; Kivelä SL
    Arch Intern Med; 1996 Jan; 156(2):205-8. PubMed ID: 8546555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions to simultaneous influenza and pneumococcal vaccination.
    McCue JD
    J Fam Pract; 1981 Aug; 13(2):175-7. PubMed ID: 7252446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
    Shinefield HR; Black S; Ray P; Chang I; Lewis N; Fireman B; Hackell J; Paradiso PR; Siber G; Kohberger R; Madore DV; Malinowski FJ; Kimura A; Le C; Landaw I; Aguilar J; Hansen J
    Pediatr Infect Dis J; 1999 Sep; 18(9):757-63. PubMed ID: 10493334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.
    Shelly MA; Jacoby H; Riley GJ; Graves BT; Pichichero M; Treanor JJ
    Infect Immun; 1997 Jan; 65(1):242-7. PubMed ID: 8975918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.
    Nakashima K; Aoshima M; Ohfuji S; Yamawaki S; Nemoto M; Hasegawa S; Noma S; Misawa M; Hosokawa N; Yaegashi M; Otsuka Y
    Hum Vaccin Immunother; 2018; 14(8):1923-1930. PubMed ID: 29561248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly.
    Sankilampi U; Honkanen PO; Pyhälä R; Leinonen M
    Vaccine; 1997 Jul; 15(10):1133-7. PubMed ID: 9269058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis.
    Bjornson AB; Falletta JM; Verter JI; Buchanan GR; Miller ST; Pegelow CH; Iyer RV; Johnstone HS; DeBaun MR; Wethers DL; Wang WC; Woods GM; Holbrook CT; Becton DL; Kinney TR; Reaman GH; Kalinyak K; Grossman NJ; Vichinsky E; Reid CD
    J Pediatr; 1996 Dec; 129(6):828-35. PubMed ID: 8969724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revaccination with 23-valent pneumococcal polysaccharide vaccine in the Japanese elderly is well tolerated and elicits immune responses.
    Kawakami K; Kishino H; Kanazu S; Toshimizu N; Takahashi K; Sterling T; Wang M; Musey L
    Vaccine; 2016 Jul; 34(33):3875-81. PubMed ID: 27265450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained functional serotype-specific antibody after primary and secondary vaccinations with a pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.
    Ohshima N; Nagai H; Matsui H; Akashi S; Makino T; Akeda Y; Oishi K
    Vaccine; 2014 Feb; 32(10):1181-6. PubMed ID: 24120483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serotype 5 pneumococcus in epidemiology and vaccine].
    Lafaix C; Meignan S; Biron G; Armand J
    Bull Eur Physiopathol Respir; 1983; 19(2):195-7. PubMed ID: 6871497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly.
    Sankilampi U; Honkanen PO; Bloigu A; Herva E; Leinonen M
    J Infect Dis; 1996 Feb; 173(2):387-93. PubMed ID: 8568300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity and antibody responses of volunteers given two or three doses of pneumococcal vaccine.
    Mufson MA; Krause HE; Schiffman G
    Proc Soc Exp Biol Med; 1984 Nov; 177(2):220-5. PubMed ID: 6483857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.